Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Participate in Research
  3. Cyclic P4/Spironolactone in PCOS
Research Study

Phase II 6-month Cyclic Progesterone/Spironolactone pilot therapy trial in Polycystic Ovary Syndrome

Principal Investigator
Jerilynn C. Prior

Overview

Body Locations and Systems
Endocrine System
Skin, Hair and Nails
Disorders and Conditions
Pregnancy and Reproduction
Status
Recruiting
Start/End Dates
Sep 1, 2021 Jun 30, 2022
Locations
Gordon and Leslie Diamond Health Care Centre
Name/Title
Kaitlin Nelson, Research Coordinator
Phone
604-875-5917
Email Address
cycles.cemcor@ubc.ca
Purpose of Study

The purpose of the study is to learn about the impacts of Cyclic Progesterone and Spironolactone on the menstrual cycles, luteinizing hormone and testosterone levels, and quality of life experiences of women living with polycystic ovary syndrome (PCOS).

Recruitment Poster

Eligibility

Individuals may be eligible to participate if you:

  • Are a woman or non-binary persons
  • Are between the ages of 19-35
  • Have been diagnosed with androgenic PCOS
  • Are not at risk for diabetes
  • Are willing to stop taking the pill or metformin for a month if you were taking either or both
  • Are willing to prevent pregnancy using provided non-hormonal contraceptives
Disclaimer

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.

Share

  • Facebook
  • Linkedin
  • Twitter
  • Email

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy